Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
US Kidney Research
AddedFeb 17, 2024
UpdatedJun 18, 2026
US Kidney Research

US Kidney Research

Seed

US Kidney Research Corp: Innovating waterless renal replacement tech for wearable and standalone devices.

HQ
Roseville, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

US Kidney Research Corporation, founded in June 2015 and formerly known as Curion Research Corporation, is a Delaware C-Corp dedicated to revolutionizing renal replacement technology. The company’s core mission is to develop the world’s first waterless renal replacement system, eliminating the need for water, dialysate concentrate solutions, and traditional dialyzers. Their primary product focus is on creating a wearable artificial kidney, with future plans to expand this technology to standalone devices. Notable achievements include winning $650,000 in the third round of the KidneyX Artificial Kidney International Contest.

The company has also been featured in a Nature Journal article discussing the potential of implantable artificial kidneys to eliminate the need for dialysis. US Kidney Research Corporation's innovative ultra-filter membrane technology has garnered significant attention and promises to make a substantial impact on the treatment of kidney disease, potentially transforming patient care and quality of life.

US Kidney Research - Similar Companies

Implantable Artificial Kidney logo

Implantable Artificial Kidney

River 3 Renal logo

River 3 Renal

Specialty Renal Products logo

Specialty Renal Products

River 2 Renal logo

River 2 Renal

Usrc Roanoke logo

Usrc Roanoke

usrenalcare.com

Nephrosant logo

Nephrosant

RenalGuard Solutions logo

RenalGuard Solutions

renalguard.com

Rejuvenate Kidney Transplant Solutions logo

Rejuvenate Kidney Transplant Solutions

Bright Uro logo

Bright Uro

brighturo.com

Reset Kidney Health logo

Reset Kidney Health

Qidni Labs logo

Qidni Labs

Nephros logo

Nephros

nephros.com

Pure Life Renal logo

Pure Life Renal

plrenal.com

Sonogenix logo

Sonogenix

NephroDI Therapeutics logo

NephroDI Therapeutics

nephrodi.com

US Kidney Research - Quick Facts

Who are US Kidney Research's competitors?

Companies similar to US Kidney Research include Implantable Artificial Kidney, River 3 Renal, Specialty Renal Products and River 2 Renal.

When was US Kidney Research founded?

US Kidney Research was founded in 2015.

Where is US Kidney Research's headquarters located?

US Kidney Research's headquarters is located in Roseville, CA, US.

When was US Kidney Research's last funding round?

US Kidney Research's most recent funding round was for $1.5M (USD) in January 2023.

How much has US Kidney Research raised to-date?

As of Jan 17, 2023, US Kidney Research has raised a total of $4M (USD).

How many employees does US Kidney Research have?

US Kidney Research has 5 employees as of Feb 5, 2024.

US Kidney Research - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified